NasdaqCM:SMTIMedical Equipment
Sanara MedTech (SMTI): Fresh Focus on Surgical Business Prompts New Look at Valuation After Earnings Beat and Business Shift
Sanara MedTech (SMTI) has caught investor attention after announcing plans to discontinue its Tissue Health Plus segment in addition to reporting strong third quarter earnings results. The company is refocusing resources on its core surgical business.
See our latest analysis for Sanara MedTech.
Sanara MedTech’s announcement to exit the Tissue Health Plus business and focus on its surgical division arrived after a volatile stretch for shareholders. Despite last week’s sharp one-day share price...